You just read:

Cefiderocol, A Novel Investigational Siderophore Cephalosporin, Demonstrated Potent Activity Against Multi-Drug Resistant Gram-Negative Pathogens

News provided by

Shionogi & Co., Ltd.

Oct 26, 2016, 08:01 ET